An Open-Label, Multi-Center, Multiple-Application Pharmacokinetic Study of NAFT-500 in Pediatric Subjects With Tinea Cruris and Tinea Pedis and NAFT-600 in Pediatric Subjects With Tinea Pedis
Latest Information Update: 12 Dec 2017
At a glance
- Drugs Naftifine (Primary)
- Indications Tinea cruris; Tinea pedis
- Focus Pharmacokinetics
- Sponsors Merz Pharmaceuticals
Most Recent Events
- 28 Apr 2015 New trial record